Join Growin Stock Community!

康科特6518.TW Overview

TW StockBiotech. & Medical
(No presentation for 6518)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

康科特(6518)Overall Performance

康科特(6518)AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

康科特(6518) PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

康科特(6518)Key Information

康科特(6518)Profile

Concord Medical Co., Ltd. provides hospital management support services in Taiwan, Myanmar, and China. It offers medical management services that include medical training and nursing staffing, and assisting on medical management; and procurement services for equipment, drugs, medical materials and consumables, inspection equipment, and reagents and consumables, as well as develops its own brand for medical beauty care products, health foods, and finished Chinese medicine products. The company is also involved in the medical equipment planning and sales; and medical equipment leasing activities. Concord Medical Co., Ltd. was founded in 2009 and is based in New Taipei City, Taiwan.

康科特(6518)FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
3.05
PE Ratio (TTM)
8.93
Forward PE
-
PS Ratio (TTM)
0.51
PB Ratio
1.32
Price-to-FCF
3.75
METRIC
VALUE
vs. INDUSTRY
Gross Margin
12.73%
Net Margin
5.75%
Revenue Growth (YoY)
5.64%
Profit Growth (YoY)
15.90%
3-Year Revenue Growth
6.88%
3-Year Profit Growth
19.30%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
3.05
PE Ratio (TTM)
8.93
Forward PE
-
PS Ratio (TTM)
0.51
PB Ratio
1.32
Price-to-FCF
3.75
Gross Margin
12.73%
Net Margin
5.75%
Revenue Growth (YoY)
5.64%
Profit Growth (YoY)
15.90%
3-Year Revenue Growth
6.88%
3-Year Profit Growth
19.30%
default symbol

6518

康科特

27.25D

0.18%

(0.00)

  • When is 6518's latest earnings report released?

    The most recent financial report for 康科特 (6518) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6518's short-term business performance and financial health. For the latest updates on 6518's earnings releases, visit this page regularly.

  • Where does 6518 fall in the P/E River chart?

    According to historical valuation range analysis, 康科特 (6518)'s current price-to-earnings (P/E) ratio is 12.04, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 6518?

    According to the latest financial report, 康科特 (6518) reported an Operating Profit of 35.71M with an Operating Margin of 7.96% this period, representing a growth of 24.01% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 6518's revenue growth?

    In the latest financial report, 康科特 (6518) announced revenue of 448.81M, with a Year-Over-Year growth rate of 3.57%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 6518 have?

    At the end of the period, 康科特 (6518) held Total Cash and Cash Equivalents of 169.65M, accounting for 0.14 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 6518 go with three margins increasing?

    In the latest report, 康科特 (6518) achieved the “three margins increasing” benchmark, with a gross margin of 13.67%%, operating margin of 7.96%%, and net margin of 6.44%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6518's profit trajectory and future growth potential.

  • Is 6518's EPS continuing to grow?

    According to the past four quarterly reports, 康科特 (6518)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.87. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 6518?

    康科特 (6518)'s Free Cash Flow (FCF) for the period is 110.11M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 106.35% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.